GHG emissions intensity, market-based

Unit

i
: MwH

Indicator

i
: GHG emissions

Metric type

i
: Pressure

Framework alignment notes

i
E1-6 53 AR 53
7.45
305-4 a 305-4 b 305-4 c 305-4 d
GHG emissions
Refer to the PSCI resources included in the Metric definition Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry and Supplier Environmental Survey for alignment to the metric
Refer to EFPIA's Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement (10.06.24) for alignment to metric
T8

Target example

[Company name] will reduce its GHG emissions intensity by [target amount, in absolute metric tonnes of CO2eq/net revenue, or percentage] by [target year], compared to a [baseline year] baseline.

Target Source: WBCSD target template

Sector

i
Pharmaceutical

Value chain stage

i
Raw Materials Manufacturing

Metric assessment

i

Relevance: High

Feasibility: High

Related actions

Set time-bound, science-based GHG reduction targets that are externally verified and aligned with climate goals

Set time-bound, science-based GHG reduction targets that are externally verified and aligned with climate goals

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce GHG emissions from operations and land use activities

Reduce GHG emissions from operations and land use activities

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Develop and implement sourcing guidelines that prioritize sustainable commodities and suppliers committed to sustainable practices

Develop and implement sourcing guidelines that prioritize sustainable commodities and suppliers committed to sustainable practices

Description

Value chain stage

Raw Materials

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon